A promising strategy change for the pharmaceutical Biovail
April 4, 2009
The revival of the pharmaceutical company Biovail (Tor., BVF, $ 13.07) is on track and could offer a good investment opportunity, according to some financial.
The revival of the pharmaceutical company Biovail (Tor., BVF, $ 13.07) is on track and could offer a good investment opportunity, according to some financial.